JP2011516510A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516510A5
JP2011516510A5 JP2011503353A JP2011503353A JP2011516510A5 JP 2011516510 A5 JP2011516510 A5 JP 2011516510A5 JP 2011503353 A JP2011503353 A JP 2011503353A JP 2011503353 A JP2011503353 A JP 2011503353A JP 2011516510 A5 JP2011516510 A5 JP 2011516510A5
Authority
JP
Japan
Prior art keywords
hydroxy
pyridin
thieno
dihydro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011503353A
Other languages
English (en)
Japanese (ja)
Other versions
JP5592348B2 (ja
JP2011516510A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/001937 external-priority patent/WO2009124636A1/en
Publication of JP2011516510A publication Critical patent/JP2011516510A/ja
Publication of JP2011516510A5 publication Critical patent/JP2011516510A5/ja
Application granted granted Critical
Publication of JP5592348B2 publication Critical patent/JP5592348B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011503353A 2008-04-11 2009-03-17 Ampにより活性化されたプロテインキナーゼ(ampk)アクチベーターとしてのチエノピリドン誘導体 Expired - Fee Related JP5592348B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08290364 2008-04-11
EP08290364.2 2008-04-11
PCT/EP2009/001937 WO2009124636A1 (en) 2008-04-11 2009-03-17 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators

Publications (3)

Publication Number Publication Date
JP2011516510A JP2011516510A (ja) 2011-05-26
JP2011516510A5 true JP2011516510A5 (cg-RX-API-DMAC7.html) 2012-05-17
JP5592348B2 JP5592348B2 (ja) 2014-09-17

Family

ID=40671017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011503353A Expired - Fee Related JP5592348B2 (ja) 2008-04-11 2009-03-17 Ampにより活性化されたプロテインキナーゼ(ampk)アクチベーターとしてのチエノピリドン誘導体

Country Status (25)

Country Link
US (1) US8563729B2 (cg-RX-API-DMAC7.html)
EP (1) EP2262500B1 (cg-RX-API-DMAC7.html)
JP (1) JP5592348B2 (cg-RX-API-DMAC7.html)
KR (1) KR101630466B1 (cg-RX-API-DMAC7.html)
CN (1) CN101998853B (cg-RX-API-DMAC7.html)
AU (1) AU2009235784B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910439B8 (cg-RX-API-DMAC7.html)
CA (1) CA2721025C (cg-RX-API-DMAC7.html)
CO (1) CO6300954A2 (cg-RX-API-DMAC7.html)
DK (1) DK2262500T3 (cg-RX-API-DMAC7.html)
EA (1) EA017756B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010599A (cg-RX-API-DMAC7.html)
ES (1) ES2584278T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20160907T1 (cg-RX-API-DMAC7.html)
HU (1) HUE027857T2 (cg-RX-API-DMAC7.html)
IL (1) IL208067A (cg-RX-API-DMAC7.html)
MX (1) MX2010011047A (cg-RX-API-DMAC7.html)
MY (1) MY155836A (cg-RX-API-DMAC7.html)
NZ (1) NZ589136A (cg-RX-API-DMAC7.html)
PL (1) PL2262500T3 (cg-RX-API-DMAC7.html)
PT (1) PT2262500T (cg-RX-API-DMAC7.html)
SI (1) SI2262500T1 (cg-RX-API-DMAC7.html)
UA (1) UA103321C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009124636A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201008050B (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20120549T1 (hr) * 2008-05-05 2012-07-31 Merck@Patent@GmbH Derivati tienopiridona kao amp aktivirani aktivatori protein kinaze ampk
DK2519527T3 (da) * 2009-12-29 2014-01-27 Poxel Thieno[2,3-b]pyridindion-aktivatorer af ampk og terapeutiske anvendelser deraf
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2552435A1 (en) 2010-04-02 2013-02-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
JP5990170B2 (ja) * 2010-09-01 2016-09-07 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 除草活性を有するケトスルタム類及びジケトピリジン類
EP2683690A1 (en) * 2011-03-07 2014-01-15 GlaxoSmithKline LLC Quinolinone derivatives
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2679591A1 (en) 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK
EP2970177A1 (en) 2013-03-15 2016-01-20 Pfizer Inc. Indole compounds that activate ampk
US9827222B2 (en) * 2013-07-01 2017-11-28 Emory University Treating or preventing nephrogenic diabetes insipidus
WO2015103480A1 (en) 2014-01-02 2015-07-09 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
CN104945369A (zh) * 2015-06-23 2015-09-30 佛山市赛维斯医药科技有限公司 一种含六甲基苯环和硝基苯结构的黄原酸酯类化合物、其制备方法及用途
CN104892569A (zh) * 2015-06-23 2015-09-09 佛山市赛维斯医药科技有限公司 末端取代的硝苯六甲苯黄原酸酯类的化合物、制备方法及用途
CN105037321A (zh) * 2015-06-23 2015-11-11 佛山市赛维斯医药科技有限公司 含六甲基苯环的黄原酸酯类的ampk激活剂、制备方法及用途
CN105037322A (zh) * 2015-06-23 2015-11-11 佛山市赛维斯医药科技有限公司 含六甲基苯环和烷氧苯结构的黄原酸酯类化合物、其制备方法及用途
CN104945370A (zh) * 2015-06-23 2015-09-30 佛山市赛维斯医药科技有限公司 含卤代噻吩和硝苯六甲苯结构的黄原酸酯类化合物、制备方法及用途
CN104892568A (zh) * 2015-06-23 2015-09-09 佛山市赛维斯医药科技有限公司 一种含六甲基苯环和腈基苯结构的黄原酸酯类化合物、其制备方法及用途
CN105037296A (zh) * 2015-06-24 2015-11-11 佛山市赛维斯医药科技有限公司 一类卤代苯双酰基苄胺类的ampk激活剂、其制备方法及用途
CN104926757A (zh) * 2015-06-24 2015-09-23 佛山市赛维斯医药科技有限公司 含烷氧苯基的双酰基苄胺类ampk激活剂、其制备方法及用途
CN104926755A (zh) * 2015-06-24 2015-09-23 佛山市赛维斯医药科技有限公司 硝苯双酰基苄胺类ampk激活剂、其制备方法及用途
CN104926756A (zh) * 2015-06-24 2015-09-23 佛山市赛维斯医药科技有限公司 一类含腈基苯的双酰基苄胺类化合物、其制备方法及用途
CN105001181A (zh) * 2015-06-24 2015-10-28 佛山市赛维斯医药科技有限公司 一类双酰基苄胺类的ampk激活剂、其制备方法及用途
CN104945372A (zh) * 2015-06-24 2015-09-30 佛山市赛维斯医药科技有限公司 一种含二硝基以及六甲苯结构的黄原酸酯类化合物、制备方法及用途
CN105001194A (zh) * 2015-06-24 2015-10-28 佛山市赛维斯医药科技有限公司 一种含氨基噻吩以及六甲苯结构的黄原酸酯类化合物、制备方法及用途
CN104945371A (zh) * 2015-06-24 2015-09-30 佛山市赛维斯医药科技有限公司 一种含腈基噻吩以及六甲苯结构的黄原酸酯类化合物、制备方法及用途
MA42456B1 (fr) * 2015-06-25 2021-06-30 Univ Health Network Inhibiteurs de hpk1 et leurs procédés d'utilisation
US20190054096A1 (en) 2015-09-30 2019-02-21 Instituto De Medicina Molecular Methods for attenuating parasite virulence
WO2018002215A1 (en) 2016-06-30 2018-01-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of cardiomyopathies
MX2021005772A (es) * 2018-11-16 2021-10-13 Poxel Sal de monohidrato potasico de un derivado de tienopiridona y su proceso de preparacion.
WO2020201263A1 (en) 2019-04-01 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of cardiac remodeling
AU2021244824A1 (en) 2020-03-26 2022-10-27 Poxel Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy
BR112022019403A2 (pt) * 2020-04-02 2022-12-06 Poxel Uso de um derivado de tienopiridona no tratamento de doença renal policística autossômica dominante (drpad)
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
EP4221700A1 (en) 2020-09-30 2023-08-09 Bioverativ Therapeutics Inc. Ampk activators and methods of use thereof
WO2022106892A1 (en) 2020-11-17 2022-05-27 Instituto De Medicina Molecular Anti-malarial compounds
JP2024540522A (ja) 2021-11-19 2024-10-31 ザ・ブロード・インスティテュート・インコーポレイテッド キナーゼを標的結合部分で標識するための二官能性キメラ分子及びその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233641A (en) 1989-05-16 1992-07-28 Merrell Dow Pharma Quinoline and thienopyridine derivatives and excitatory amino acid antagonistic pharmaceutical compositions
DE4444815A1 (de) 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
GB0214268D0 (en) * 2002-06-20 2002-07-31 Celltech R&D Ltd Chemical compounds
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
CA2714181C (en) 2008-02-04 2013-12-24 Mercury Therapeutics, Inc. Ampk modulators

Similar Documents

Publication Publication Date Title
JP2011516510A5 (cg-RX-API-DMAC7.html)
HRP20160907T1 (hr) Derivati tienopiridona kao aktivatori amp-aktivirane protein kinaze (ampk)
JP2011519876A5 (cg-RX-API-DMAC7.html)
HRP20120549T1 (hr) Derivati tienopiridona kao amp aktivirani aktivatori protein kinaze ampk
CA2473591C (en) 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
JP2016196492A5 (cg-RX-API-DMAC7.html)
HRP20170246T4 (hr) Režim doziranja za selektivni agonist s1p1-receptora
JP2014518884A5 (cg-RX-API-DMAC7.html)
RU2002114338A (ru) Арил-и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования повторного поглощения норепинефрина, допамина и серотонина
JP5965484B2 (ja) ジフルオロメチレン化合物
CA2474460A1 (en) Pyridine- and quinoline-derivatives
JP2007519753A5 (cg-RX-API-DMAC7.html)
TWI633105B (zh) 新型urat1抑制劑及其在醫藥上的應用
JP2005514432A5 (cg-RX-API-DMAC7.html)
JP2015510894A5 (cg-RX-API-DMAC7.html)
CN110386941A (zh) Ep4受体拮抗剂和pd-1抑制剂联合用于癌症的治疗
AR088208A1 (es) Inhibidores de la monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y trastornos relacionados
AU2014241390A1 (en) GPR120 agonists for the treatment of type II diabetes
JP2011525502A5 (cg-RX-API-DMAC7.html)
AU2020276005A1 (en) 3-aryloxyl-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof
CA2577879A1 (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon.
AU2015281799B2 (en) Enzyme interacting agents
JP2012500232A5 (cg-RX-API-DMAC7.html)
KR100888093B1 (ko) 약제학적 활성 화합물 및 이의 사용 방법
HRP20210052T1 (hr) Modulatori adenozinskog receptora a3